Patent application number | Description | Published |
20100154105 | TREATED CUFF - The present invention is generally directed to an elastic woven cuff having an alcohol repellency rating of 10, the cuff having fluoro-chemical monomer deposited onto the surface of the cuff | 06-24-2010 |
20120164901 | NONWOVEN WEBS HAVING IMPROVED BARRIER PROPERTIES - Methods of manufacturing a nonwoven web having alcohol repellency properties are provided. A plurality of perfluoroalkyl(alkyl)(meth)acrylic monomers can first be deposited on a surface of the nonwoven web, and subsequently exposed to a RF plasma to polymerize the monomers on the surface of the nonwoven web to form a fluorinated polymeric coating. The perfluoroalkyl(alkyl)(meth)acrylic monomers include perfluoroalkyl(alkyl)(meth)acrylate esters having a perfluorinated carbon end group of 1 to 6 carbon atoms | 06-28-2012 |
20120164906 | NONWOVEN WEBS HAVING IMPROVED BARRIER PROPERTIES - A laminate is generally provided having alcohol repellency properties. In one particular embodiment, the laminate includes a meltblown web bonded to a spunbond web (e.g., a SM laminate, a SMS laminate, a SMMS laminate, etc.). A fluorinated polymeric coating is attached to the surface of the spunbond web (e.g., grafted). The fluorinated polymeric coating comprises a perfluoroalkyl(alkyl) (meth)acrylate monomer polymerized on the surface of the spunbond web via exposure to a low frequency energy source. The perfluoroalkyl(alkyl) (meth)acrylate monomer has a perfluoroalkyl side groups comprising —(CF | 06-28-2012 |
20130109263 | Abrasion-Resistant Nonwovens | 05-02-2013 |
Patent application number | Description | Published |
20080288866 | MOBILE DEVICE CARROUSEL SYSTEMS AND METHODS - Receiving a first plurality of media presentations; outputting the first plurality of media presentations to a user of a mobile telephone in a first sequential presentation of the first plurality of media presentations at least until the user selects one of the first plurality of media presentations; outputting a second sequential presentation of the first plurality of media presentations to the user if the user does not select a media presentation during the first sequential presentation of the first plurality of media presentations; receiving a first user input corresponding to a first selected media presentation among the first plurality of media presentations; and outputting at least a first media item corresponding to the first selected media presentation responsive to receiving the first user input. | 11-20-2008 |
20100091958 | AUTO BLOCK AND AUTO DISCOVERY IN A DISTRIBUTED COMMUNICATION SYSTEM - A voicemail system enabling various components of the voicemail system to be distributed geographically yet operate as a seamlessly integrated system is disclosed. A signal gateway interfaces with a telephone network. In addition, one or more media servers interface with the signal gateway as well as the telephone network. The signal gateway is configured to block calls to malfunctioning media servers. The signal gateway monitors the media servers, and responsive to determining that a media server has malfunctioned, the signal gateway initiates auto-blocking such that the telephone network does not route calls to the malfunctioning media server. In addition, the signal gateway is configured to auto-detect a media server responsive to the media server being initialized. The voicemail system can include a variety of other elements, such as one or more system management units and one or more central data and message store systems. Each of the elements in the voicemail system communicate with each other over an internet protocol type network. Any functions in the various elements that require interfacing with the telephone network are simply handled through the signal gateway. | 04-15-2010 |
20100232582 | SYSTEM AND METHOD FOR OUTBOUND CALLING FROM A DISTRIBUTED TELECOMMUNICATIONS PLATFORM - Outbound calling from a Voice eXtensible Markup Language (VXML) based voicemail system, which has distributed architecture, is disclosed. The voicemail system includes a media server, which is in communication with a telephone network. The media server includes multiple communication termination-link components, and the communication termination-link components are adapted to couple to trunks that extend to the telephone network. The media server also includes a network interface that is adapted to receive and provide communications to components of the telecommunications platform. The media server also includes a link-selector, a browser module, and a processor. The link-selector is adapted to select a given communication termination-link component from the plurality of communication termination-link components. The browser module is adapted to provide a browser session, which is associated with the given communication termination link, and the processor implements the link-selector and the browser module in responsive receiving an outbound notification via the network interface. | 09-16-2010 |
20100232583 | System and Method for Message Storage Assurance in a Geographically Distributed Voice Messaging System - A voice messaging system comprises a common message store, a local data store located remotely from the common message store, and a media server. The media server is operable to receive a call directed to a number serviced by the media server, prompt the user for a voice message, direct the voice message to the local data store for temporary storage, notify the common message store that the voice message is present in the local data store, respond to a request to transfer the voice message to the common message store, and direct the local data store to erase the message upon receipt of a communication from the common message store that the voice message was successfully saved. | 09-16-2010 |
20100248759 | Provision of Messaging Services From a Video Messaging System for Video Compatible and Non-video Compatible Equipment - A telecommunications system that supports the provision of video messaging, yet maintains compatibility and operation with user equipment that is not capable of processing, receiving or rendering video content. Based on the type of user equipment, as well as user selected options, network configurations and status, and class-of-service characteristics, the telecommunications systems can revise the manner in which content is provided to the user equipment. Variations in the content provision include providing synchronized audio and video content, audio content only, video content only, video content with closed-captioning and closed-captioning only. | 09-30-2010 |
20110051717 | SYSTEM AND METHOD FOR PROVIDING REDUNDANCY IN A DISTRIBUTED TELECOMMUNICATIONS ARCHITECTURE - A telecommunications platform that provides redundant interfaces to a telecommunications system for multiple IP based telecommunication devices. The telecommunications platform includes a gateway cluster with two or more signaling gateways. Each signaling gateway is assigned a point code for being accessed by devices in the telecommunications system. The gateway cluster is assigned a virtual point code. Any of the IP based telecommunications devices can be accessed by the telecommunications system by routing to the virtual point code through one of the signaling gateways in the gateway cluster. Thus, if one of the signaling gateways is not available, the IP based telecommunications devices can still be accessed through one of the other signaling gateways in the gateway cluster. | 03-03-2011 |
Patent application number | Description | Published |
20120078378 | PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME - Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane. | 03-29-2012 |
20130129836 | PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME - Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane. | 05-23-2013 |
20130202676 | CROSS-LINKED DEHYDRATED PLACENTAL TISSUE GRAFTS AND METHODS FOR MAKING AND USING THE SAME - Described herein are tissue grafts produced by contacting dehydrated placental tissue grafts with a cross-linking agent. The tissue grafts described herein provide barrier and prevent the migration of a bioactive agent from the wound. Thus, the tissue grafts enhance wound healing while preventing the undesirable migration of a bioactive agent from the wound. Methods for making and using the cross-linked grafts are also described herein. | 08-08-2013 |
20130218274 | SHREDDED TISSUE GRAFTS AND METHODS FOR MAKING AND USING THE SAME - Described herein are shredded tissue grafts composed of one or more placental components. The compositions have numerous medical applications with respect to wound healing and complications associated with wound healing. Methods for making the shredded tissue graft compositions are also described herein. | 08-22-2013 |
20130224159 | PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME - Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane. | 08-29-2013 |
20130230561 | PLACENTAL TISSUE GRAFTS PRODUCED BY CHEMICAL DEHYDRATION/FREEZE-DRYING AND METHODS FOR MAKING AND USING THE SAME - Described herein are placental tissue grafts produced by chemical dehydration followed by freeze-drying the placental tissue to produce the tissue graft. The tissue grafts retain their biological properties preferably at the same level as the placental tissues before they are processed. The placental tissue grafts have numerous medical applications. Methods for making the tissue graft compositions are also described herein. | 09-05-2013 |
20130344162 | MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME - Described herein are composition composed of micronized placental components and pharmaceutical compositions thereof. The compositions have numerous medical applications. Methods for making and using the micronized compositions are also described herein. | 12-26-2013 |
20140017280 | MICRONIZED COMPOSITIONS COMPOSED OF BONE GRAFTS AND METHODS OF MAKING AND USING THE SAME - Described herein are compositions composed of micronized particles derived from one or more components present in placental tissue in combination with one or more bone grafts. The compositions have numerous medical applications. Methods for making and using the micronized compositions are also described herein. | 01-16-2014 |
20140052247 | Placental tissue grafts modified with a cross-linking agent and methods of making and using the same - Described herein are tissue grafts derived from the placenta that possess good adhesion to biological tissues and are useful in would healing applications. In one aspect, the tissue graft includes (1) two or more layers of amnion, wherein at least one layer of amnion is cross-linked, (2) two or more layers of chorion, wherein at least one layer of chorion is cross-linked, or (3) one or more layers of amnion and chorion, wherein at least one layer of amnion and/or chorion is cross-linked. In another aspect, the grafts are composed of amnion and chorion cross-linked with one another. In a further aspect, the grafts have one or more layers sandwiched between the amnion and chorion membranes. The amnion and/or the chorion are treated with a cross-linking agent prior to the formation of the graft. The presence of the cross-linking agent present on the graft also enhances adhesion to the biological tissue of interest. Also described herein are methods for making and using the tissue grafts. | 02-20-2014 |
20140052274 | Tissue grafts composed of micronized placental tissue and methods of making and using the same - Described herein are tissue grafts composed of at least one membrane, where at least one side of the membrane has micronized placental tissue applied it. Also described herein are methods for making and using the tissue grafts. | 02-20-2014 |
20140255508 | MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME - Described herein are composition composed of micronized placental components and pharmaceutical compositions thereof. The compositions have numerous medical applications. Methods for making and using the micronized compositions are also described herein. | 09-11-2014 |
20140302162 | MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME - Described herein are composition composed of micronized placental components and pharmaceutical compositions thereof. The compositions have numerous medical applications. Methods for making and using the micronized compositions are also described herein. | 10-09-2014 |
Patent application number | Description | Published |
20130317624 | PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME - Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane. | 11-28-2013 |
20140050788 | MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME - Described herein are compositions composed of micronized placental components, extracts of micronized placental components, and pharmaceutical compositions thereof. The compositions have numerous medical applications. Methods for making and using the micronized compositions and the extracts thereof are also described herein. | 02-20-2014 |
20140205646 | TISSUE GRAFTS MODIFIED WITH A CROSS-LINKING AGENT AND METHOD OF MAKING AND USING THE SAME - Described herein are tissue grafts derived from the placenta that possess good adhesion to biological tissues and are useful in would healing applications. In one aspect, the tissue graft includes (1) two or more layers of amnion, wherein at least one layer of amnion is cross-linked, (2) two or more layers of chorion, wherein at least one layer of amnion is cross-linked, or (3) one or more layers of amnion and chorion, wherein at least one layer of amnion and/or chorion is cross-linked. In another aspect, the grafts are composed of amnion and chorion cross-linked with one another. In a further aspect, the grafts have one or more layers sandwiched between the amnion and chorion membranes. The amnion and/or the chorion are treated with a cross-linking agent prior to the formation of the graft. Also described herein are methods for making and using the tissue grafts. | 07-24-2014 |
20140255496 | MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME - Described herein are compositions composed of micronized placental components, extracts of micronized placental components, and pharmaceutical compositions thereof. The compositions have numerous medical applications. Methods for making and using the micronized compositions and the extracts thereof are also described herein. | 09-11-2014 |
20140343688 | LAMINATED TISSUE GRAFTS COMPOSED OF WHARTON'S JELLY AND METHODS OF MAKING AND USING THE SAME - Described herein are tissue grafts derived from the placenta with improved physical and biological properties. In one aspect, the tissue graft includes a first membrane comprising Wharton's jelly laminated with amnion, chorion, or a combination thereof. The presence of Wharton's jelly in the grafts enhances the performance of allograft amniotic-derived, caderivic allograft, xenograft, or alloplast soft tissue substitutes. | 11-20-2014 |
20150250829 | MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME - Described herein are compositions composed of micronized placental components, extracts of micronized placental components, and pharmaceutical compositions thereof. The compositions have numerous medical applications. Methods for making and using the micronized compositions and the extracts thereof are also described herein. | 09-10-2015 |
Patent application number | Description | Published |
20100104539 | PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME - Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane. | 04-29-2010 |
20120294908 | PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME - Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane. | 11-22-2012 |
20120294909 | METHOD FOR INHIBITING ADHESION FORMATION - Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane. | 11-22-2012 |
20120294910 | METHOD FOR TREATING A WOUND - Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane. | 11-22-2012 |
20130197665 | PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME - Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane. | 08-01-2013 |
20140214176 | PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME - Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane. | 07-31-2014 |
20140234387 | PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME - Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane. | 08-21-2014 |
20140290837 | PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME - Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane. | 10-02-2014 |
20140322289 | PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME - Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane. | 10-30-2014 |
Patent application number | Description | Published |
20130342623 | LABEL PRINTING APPARATUS - A method of creating a label to be printed on a label printing apparatus comprising: determining at least one option to be made available to a user relating to a label-creating process; displaying said at least one option on a display; and enabling a user to select said at least one option; wherein said determination of the at least one option to be made available to the user is based upon at least one parameter. | 12-26-2013 |
20130342856 | LABEL PRINTING APPARATUS - A method of creating a label to be printed on a label printing apparatus comprising: determining at least one option to be made available to a user relating to a label-creating process; displaying said at least one option on a display; and enabling a user to select said at least one option; wherein said determination of the at least one option to be made available to the user is based upon at least one parameter. | 12-26-2013 |
20140198323 | User Interface for a Label Printer - A method including providing a first image on a label printer user interface, wherein the first image is representative of a label to be printed or an object to which a label is to be applied; and providing a second image on the user interface associated with the first image, said second image representative of a dimension of the first image; enabling a user to modify a dimension of the second image; wherein as the dimension of said second image is modified, the dimension of the first image is correspondingly updated. | 07-17-2014 |
20140268190 | LABEL FILES - A method including selecting a type of label to be printed, inputting information for the label to be printed, wherein the information includes label data defining content of an image to be printed, and parameter data defining at least one parameter of the label to be printed, saving the information for the label to be printed as a file in a memory, and providing the file with a file extension name indicative of the type of label. | 09-18-2014 |
20140281937 | USER INTERFACE FOR LABEL PRINTER - A method including providing in a first region of a user interface a label preview region for displaying an image of at least one label to be printed; providing in a second region of the user interface a data input area comprising two or more cells for input label data; wherein each cell in the data input area corresponds with the image of at least one label to be printed or at least one region of the image of at least one label to be printed. | 09-18-2014 |